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Bacillus species at the Canberra Airport: A comparison of real-time polymerase chain reaction and 
massively parallel sequencing for identification
Abstract
Anthrax, caused by the Gram-positive, spore forming bacterium Bacillus anthracis, is a disease with 
naturally occurring outbreaks in many parts of the world, primarily in domestic and wild herbivores. 
Due to the movement of people and stock, B. anthracis could, however, be at transportation hubs 
including airports. The continuous threat to national and international security from a biological 
agent release, or hoax attack, is a very real concern. Sensitive, robust and rapid methods to identify 
biological agents, including B. anthracis, and distinguish pathogenic from non-pathogenic species, is 
an essential cornerstone to national security. The aim of this project was to determine the presence 
of Bacillus species at the Canberra Airport using two massively parallel sequencing (MPS) approaches 
and compare with previous results using real-time polymerase chain reaction (qPCR).
Samples were collected daily for seven days each month from August 2011 – July 2012 targeting 
movement of people, luggage and freight into and out of the Canberra Airport. Extracted DNA was 
analysed using qPCR specific for B. anthracis. A subset of samples was analysed using two MPS 
approaches. Approach one, using the Ion PGM™ (Thermo Fisher Scientific; TFS) and an in-house 
assay, targeted the two B. anthracis virulence plasmids (cya and capB genes) and a single conserved 
region of the 16S rRNA gene. Approach two, using the Ion S5™ (TFS) and the commercial Ion 16S™ 
Metagenomics Kit (TFS), targeted multiple regions within the bacterial 16S rRNA gene.
Overall there was consistency between the two MPS approaches and between MPS and qPCR, 
however, MPS was more sensitive, particularly for plasmid detection. Whilst the broad-range 16S 
genomic target(s) used in both MPS approaches in this study was able to generate a metagenomic 
fingerprint of the bacterial community at the Canberra Airport, it could not resolve Bacillus species 
beyond the level of the B. cereus group. The inclusion of B. anthracis virulence plasmid targets in the 
in-house assay did allow for the potential presumptive identifications of pathogenic species. No 
plasmid targets were in the Ion 16S™ Metagenomics Kit. 
This study shows the choice of target(s) is key in MPS assay development and should be carefully 
considered to ensure the assay is fit for purpose, whether as an initial screening (presumptive) or a 
more specific (but not entirely confirmatory) test. Identification approaches may also benefit from a 
combination of MPS and qPCR as each has benefits and limitations.
Key words: Bacillus; massively parallel sequencing, real-time polymerase chain reaction; Canberra 
Airport.
1.0 Introduction
Anthrax, caused by the Gram-positive, spore forming bacterium Bacillus anthracis, is a disease with 
naturally occurring outbreaks in many parts of the world, primarily in domestic and wild herbivores 
such as sheep, cattle, goats and horses. Outbreaks are due to reservoirs of dormant spores which 
persist in the environment for decades and germinate into disease causing bacteria upon favourable 
conditions such as a live host. Within Australia, outbreaks are mainly limited to livestock in grazing 
regions of Victoria and New South Wales, in a region known as the ‘anthrax belt’ (Durrheim et al., 
2009), however, due to the movement of people and stock, B. anthracis could be present outside 
this region, including at transport hubs like airports.
Natural outbreaks in the human population are uncommon and are generally related to occupational 
exposure to infected animals or their products. However, in addition to natural outbreaks, B. 
anthracis has gained renewed attention since 2001 as a bioterrorism agent. This was a result of the 
highly publicised United States (US) letter attacks in which B. anthracis (Ames strain) spores were 
sent through the mail causing 22 cases of anthrax, five deaths and the widespread contamination of 
the US postal system (Jernigan et al., 2002). Furthermore, there has been a significant increase in 
reports of suspected hoaxes, ranging from ‘everyday’ white powders (such as flour and baking 
powder) to biological hoax agents (such as non-pathogenic species) (Leask et al., 2003). Biological 
hoax agents are difficult to detect if they share similar phenotypic and genetic characteristics with 
hazardous biological agents. This is especially the case for the Bacillus genus, specifically B. 
thuringiensis, a member of the B. cereus group, which is a well-established biological hoax agent, 
comparable genetically and microscopically to B. anthracis (Leask et al., 2003). Bioinsecticides 
containing B. thuringiensis spores such as Dipel (Nature’s Way Caterpillar Killer, Yates) are readily 
available for public purchase.
B. anthracis is distinguished by two virulence factors: one is responsible for the synthesis of the 
anthrax toxin and the other produces a poly-D-glutamic acid capsule. These factors are encoded onto 
two virulence plasmids, pXO1 and pXO2, respectively (for a review see Koehler, 2009). Assays to 
detect pathogenic B. anthracis and distinguish it from non-pathogenic strains and other members of 
the B. cereus group, need to target both a conserved genomic marker as well as markers for the two 
virulence plasmids. Two molecular-based methods for the detection of Bacillus species are real-time 
polymerase chain reaction (qPCR) and massively parallel sequencing (MPS).
We have previously reported background levels of B. anthracis at the Canberra Airport over the 
period August 2011 – July 2012 using single-plex qPCR with a B. anthracis genomic (PL3 gene) and 
two plasmid (cya and capB genes) targets (Gahan et al., 2015). A total of 575 samples were collected 
from areas targeting the movement of people, luggage and freight in and out of the airport. Of 
these, fourteen samples were PL3 positive, 24 were positive for cya (pXO1) and five for capB (pXO2). 
No samples were positive for all three targets. Limitations of the qPCR assay are that it only allowed 
detection of bacteria for which the primers were specifically targeted, and it was a single-plex assay 
so separate reactions (one for each target) had to be run. Furthermore, it may not have been 
sensitive enough to pick up trace concentrations of bacteria.
MPS has allowed high-throughput genetic fingerprinting of microorganisms responsible for 
outbreaks and played an important role in biosurveillance and biosecurity (Chin et al., 2011; Grad et 
al., 2012; Leekitcharoenphon et al., 2016). MPS enables the detection and characterisation of 
multiple microorganisms in mixtures, whether abundant or trace, intact or degraded. Until recently a 
major drawback of MPS has been the long run times. However, the development of bench-top 
platforms with easy to use, cost-efficient and streamlined workflows, have reduced identification 
times (Salipante et al., 2014; Whiteley et al., 2012). Targeted sequencing of species-specific and even 
strain-specific markers on bench-top platforms can enable the differentiation of pathogenic from 
non-pathogenic strains.
The aim of this project was to determine the presence of Bacillus species, in a sub-set of samples 
collected from the Canberra Airport, using two MPS approaches and compare findings to the 
previous qPCR results. Approach one used the Ion PGM™ (Thermo Fisher Scientific (TFS)) and an in-
house assay targeting the two B. anthracis virulence plasmids (cya and capB genes) and a conserved 
region of the 16S rRNA gene. Approach two used the Ion S5™ (TFS) and the commercial Ion 16S™ 
Metagenomics Kit (TFS) which targeted multiple hypervariable regions of the bacterial 16S rRNA 
gene.
2.0 Materials and Methods
2.1 Samples
B. anthracis Sterne strain (pXO1+ pXO2-) and B. thuringiensis subsp. Kurstaki were provided by the 
Australian Federal Police. Bacterial strains were initiated from frozen glycerol stocks containing a 
50:50 suspension of nutrient broth media and sterile glycerol stored at -80  ̊C and cultured in either 
nutrient broth (Oxoid) or on nutrient agar (Oxoid). Media was sterilised by autoclaving for 20 
minutes at 121  ̊C. Broth cultures were incubated for 18 hours at 37  ̊C with shaking at 210 – 240 
revolutions per minute and agar plates were incubated aerobically at 37  ̊C for 18 – 20 hours. 
Environmental samples were collected and DNA extracted as previously detailed by Gahan et al. 
(2015). Briefly, 575 samples were collected from six different sites within and around the Canberra 
Airport (Canberra, Australian Capital Territory, Australia) over a 12-month period (August 2011 – July 
2012). Collection sites corresponded to the movement of people, luggage and freight (Australian Air 
Express) arriving and departing the Canberra Airport. A low foot traffic control was also included. 
DNA was extracted using the QIAamp DNA extraction mini kit (QIAGEN) with an additional bead-
beating disruption step using 0.1 mm glass beads (Gahan et al., 2015).
Twenty DNA samples that were positive for at least one of the PL3, cya and capB targets reported by 
Gahan et al. (2015) were selected for sequencing using the in-house sequencing assay (MPS 1) and 
of these, eight were sequenced using the commercial Ion 16S™ Metagenomics Kit (MPS 2) (Table 1).
Table 1: Canberra Airport samples selected for sequencing
Sample name Description 
(Date and sample location)
In-house 
sequencing assay
(MPS 1)
Ion 16S™ 
Metagenomics Kit
(MPS 2)
CA9POV20.2 20/02/2012, People out Yes Yes
CA9LC20.2 20/02/2012, Low traffic control Yes No
CA9PO21.2 21/02/2012, People out Yes No
CA9LO21.2 21/02/2012, Luggage out Yes No
CA11LO23.4 23/04/2012, Luggage out Yes Yes
CA11PO29.4 29/04/2012, People out Yes No
CA11LI29.4 29/04/2012, Luggage in Yes No
CA9LO20.2 20/02/2012, Luggage out Yes Yes
CA9LC24.2 24/02/2012, Low traffic control Yes No
CA9LC25.2 25/02/2012, Low traffic control Yes Yes
CA9POV21.2 21/02/2012, People out Yes Yes
CA13LO21.6 21/06/2012, Luggage out Yes No
CA7FI19.12 19/12/2011, Freight in Yes Yes
CA13LO20.6 20/06/2012, Luggage out Yes Yes
CA9LI20.6 20/06/2012, Luggage in Yes No
CA9POV22.2 22/02/2012, People out Yes No
CA9LO24.2 24/02/2012, Luggage out Yes No
CA9LO25.2 25/02/2012, Luggage out Yes Yes
CA11POV29.4 29/04/2012, People out Yes No
S56FO20.8 20/08/2011, Freight out Yes No
2.2 In-house assay (MPS 1)
2.2.1 PCR enrichment and pooling
Oligonucleotide primers (Table 2) were purchased from GeneWorks. Three regions were targeted, 
the 16S rRNA conserved genetic region (Antolinos et al., 2012), the cya gene on pXO1 and the capB 
gene on pXO2 (Wielinga et al., 2011). Primers were verified using BLAST and Primer-Blast NCBI to 
ensure specificity to B. anthracis for cya and capB and broad range for the 16S rRNA target. The 
latter was to ensure detection of a range of Bacillus species and Escherichia coli.
Table 2: Oligonucleotide primers for polymerase chain reaction enrichment
Forward (F) and reverse (R) primer sequences with approximate amplicon length in base pairs (bp).
Enrichment PCRs contained 5U/μL MyTaq DNA polymerase and MyTaq Reaction Buffer (QIAGEN), 
0.4 μM (16S rRNA and capB) or 0.2 μM (cya) of each forward and reverse primer, 400 ng of bovine 
serum albumin, up to 1 ng DNA and DNAse free water to a total volume of 50 μL. Positive controls 
containing a known concentration of B. anthracis Sterne strain DNA (85 ng) and B. thuringiensis 
subsp. Kurstaki DNA (100 ng) and two negative controls (no-template control (NTC) and TE (10 mM 
Tris-HCl, 0.1 mM EDTA, pH 8.0)), were included. 
PCR enrichment was carried out in a GeneAmp® PCR system 9700 (Applied Biosystems). Reaction 
conditions comprised of an initial denaturation at 95 °C for 10 minutes followed by 35 cycles of 95 °C 
for 15 seconds, 55 °C (capB) or 56 °C (cya) or 58 °C (16S rRNA) for 30 seconds and 72 °C for 30 
seconds. Amplified products were subjected to a final 72 °C extension for three minutes.
PCR products were visualised using 1 % agarose gels in 1x Tris-acetate-EDTA buffer to confirm 
correct size and a single product. The DNA yield of each PCR amplification was quantified using 
PicoGreen® intercalating dye fluorescence (Qubit® 2.0 fluorometer; Invitrogen), according to the 
manufacturer’s protocol. 
Equimolar pools of the three amplicons (capB, cya and 16S rRNA) for each sample, in a total volume 
of 40 μL, were transferred into 1.5 μL LoBind tubes (Eppendorf), homogenised and purified using an 
AMPure XP bead (Beckman Coulter) clean-up step with MagnaRack™ (TFS). Briefly, 36 μL (0.9 x 
pooled PCR volume) of AMPure XP beads were homogenised and incubated with the pooled DNA 
targets at room temperature (RT) for 5 minutes then placed on the MagnaRack™ for 5 minutes. To 
remove larger DNA fragments, 70 μL of supernatant was transferred to a new 1.5 mL LoBind tube 
and the beads were discarded. To bind target DNA an additional 64 μL (1.6 x pooled PCR volume) 
AMPure XP beads were homogenised and incubated with the pooled targets at RT for 5 minutes 
then placed on the MagnaRack™ for 5 minutes. The supernatant was removed, and the beads were 
washed twice with 200 μL of 80 % ethanol then dried for 15 minutes. To elute the target DNA, 28 μL 
of nuclease-free water was added. A total of 25 μL of supernatant was stored at -4 °C.
DNA quantity and quality post-purification was evaluated on the 2100 Bioanalyzer instrument 
(Agilent Technologies) with the DNA 1000 Bioanalyzer kit and chips (Agilent Technologies) according 
to the manufacturer’s protocol.
Primer Primer sequence (5' → 3') Gene target Amplicon 
length (bp)
cya (F)
cya (R)
capB (F)
capB (R)
16S rRNA (F)
16S rRNA (R) 
AGGTAGATTTATAGAAAAAAACATTACGGG
GCTGACGTAGGGATGGTATT
AGCAAATGTTGGAGTGATTGTAAATG
AAAGTAATCCAAGTATTCACTTTCAATAG
AATAAGCGTCGTCAGGAACG
AGCCAGGATCAAACTCTCCA
Oedema factor (pXO1)
Capsule synthesis 
component B (pXO2)
16S rRNA
150
148
184
2.2.2 Library preparation
Library construction for targeted Ion PGM™ sequencing involved the following QIAGEN workflow: 
end-repair of PCR products (GeneRead DNA library L core kit), adapter ligation (GeneRead DNA 
Adapter L set 12 plex kit), DNA purification post-adapter ligation (Appendix B: Library Construction 
Using the GeneRead Library Prep Kits for Ion PGM™ Sequencer/Proton, from the GeneRead DNAseq 
Targeted Panels V2 Handbook (2015)), amplification of library (GeneRead DNA L Amp kit) and a final 
purification step. 
For end-repair, 20.5 μL (10 – 200 ng) of purified target DNA is recommended. However, since the 
DNA concentrations of the purified amplicons were low, these were not diluted prior to end-repair 
and the maximum volume (25 μL) was used. For adapter-ligation, 12 barcode (Bc) adapters from 
QIAGEN were utilised to label amplicons and corresponded to sample 1 (Bc 1) – sample 12 (Bc 12) on 
each of two Ion 314™ semiconductor chips, giving a total of 24 samples. 
The 2100 Bioanalyzer with a DNA 1000 kit was employed for quality control after the final 
purification step. DNA molarity (nM) was measured by integrating the area under the amplicon size 
range using the 2100 Bioanalyzer smear analysis software according to the manufacturers’ protocol. 
The DNA controls of B. anthracis Sterne strain and B. thuringiensis subsp. Kurstaki were diluted to 8 
pM prior to library pooling. Canberra Airport samples were used undiluted because they were all <8 
pM. Aliquots of 2.5 μL of each of the 12 purified samples (per chip) were pooled and homogenised 
for a total of 2 × 30 μL. For template preparation, subsequent aliquots of 2 × 25 μL from the previous 
pooling step were utilised. 
2.2.3 Template preparation
Template preparation was performed on an Ion OneTouch™ 2 (OT2) (TFS) and an Ion OneTouch™ 2 
ES (OT-ES; TFS) using the Ion PGM™ Hi-Q OT2 200 kit (TFS) according to the Quick Reference Ion 
PGM™ Hi-Q Template guide (TFS) from step 2. Enriched Ion Sphere Particles (ISPs) were briefly 
stored at -4 °C prior to sequencing.
2.2.4 Sequencing
Sequencing was performed on an Ion PGM™ sequencer using two Ion 314™ v2 Chips (TFS) in 
combination with the Ion PGM™ Hi-Q Sequencing kit chemistry (TFS) according to table 3 and the 
Quick Reference Ion PGM™ Hi-Q Sequencing guide (TFS). The three target BED files for 16S rRNA, cya 
and capB gene regions are located in the supplementary material.
Table 3: Ion PGM™ sequencing conditions
16S rRNA BA_genome(Bacillus anthracis str. ‘Ames ancestor’ complete 
genome)
cya gene BA_pXO1(Bacillus anthracis str. ‘Ames ancestor’ plasmid pXO1 
complete genome)
Reference 
genomes
capB gene BA_pXO2(Bacillus anthracis str. ‘Ames ancestor’ plasmid pXO2 
complete genome)
16S rRNA ba_genome(27_4).bed
cya gene ba_pxo1(27_4).bedTarget regions
capB gene ba_pxo2(27_4).bed
Target technique TargetSeq DNA
Template kit Ion PGM™ Hi-Q OT2 kit – 200
Sequencing kit Ion PGM™ Hi-Q Sequencing kit
Number of flows 500
Chip type Ion 314™ Chip v2
Barcode set GeneRead DNA Adapter L set 12 plex kit
Plugins Coverage analysis and FileExporter
2.2.5 Data analysis
Sequencing output files were exported in FASTQ format by the FileExporter plugin in Torrent™ Suite 
Software (TFS).
FASTQC (Andrews, 2010) was utilised to extract read quality control data from the FASTQ files. Reads 
that passed default parameters were mapped to the genome of B. anthracis Ames ancestor (NCBI 
entries: chromosome NC_007530.2; pXO1 NC_007322.2; pXO2 NC_007323.3) using Bowtie2 
(Langmead et al., 2012). SAMtools (Li et al., 2009) was used to convert from SAM to BAM format and 
to generate variant call files (VCF). Sorted and indexed BAM files were converted to FASTA format by 
Picard tools (Picard, 2014) and Seqtk (Li, GitHub, year 2012). The FASTA files were then imported 
into MATLAB® using the Bioinformatics toolbox to assist in graphically visualising the target clusters 
with stacked bar graphs.
2.3 Ion 16S™ Metagenomics Kit (MPS 2)
Amplicons were prepared using the Ion 16S™ Metagenomics Kit (TFS) according to the 
manufacturer’s user guide (Revision C.0) using 2 µL sample and with PCR cycles increased from 25 to 
30. Positive (E. coli) and negative controls, included with the kit, were also prepared and sequenced. 
The kit includes two primer sets (V2-4-8 and V3-6, 7-9) that amplify the corresponding hypervariable 
regions of the 16S region in bacteria. Libraries were prepared using the Ion Plus Fragment Library Kit 
(TFS) and quantified using the Ion Universal Library Quantitation Kit (TFS) both according to the 
manufacturer’s protocol. Libraries were diluted to 30 pM and templating and sequencing preformed 
using an Ion 520™ & 530™Kit-Chef (TFS). Sequencing was done using a single Ion 520™ chip using 
850 nucleotide flows. Basecalling and alignment was done using Torrent Suite Software v5.4.
Data was analysed using the 16S Metagenomics workflow within the Ion Reporter Software (TFS). 
Briefly, the software reports the sequencing results separately for each hypervariable 16S region 
targeted with the Ion 16S™ Metagenomics Kit. Sequencing identifications are reported from the 
phylum down to the species level, along with scores for aspects including % identification, % total 
reads, % mapped reads and total counts. It is important to note the 16S™ Metagenomics Kit can only 
report identification down to the B. cereus group level which is given as Bacillus anthracis/Bacillus 
cereus/Bacillus mycoides/Bacillus thuringiensis/Bacillus weihenstephanensis.
3.0 Results 
3.1 In-house assay (MPS 1)
Using agarose gel electrophoresis, the optimised 16S rRNA assay was found to detect PCR products 
from B. anthracis Sterne strain, B. thuringiensis subsp. Kurstaki, B. thuringiensis subsp. Israelensis, B. 
cereus, B. subtilis and E. coli (data not shown). The cya assay was specific for the intended plasmid 
target for B. anthracis Sterne strain, showing no cross-reactivity amongst closely related Bacillus 
species and E. coli (data not shown). As pathogenic strains of B. anthracis (pXO1+ pXO2+) are highly 
regulated Tier one agents, this study used a non-pathogenic model strain of Sterne (pXO1+ pXO2-). 
However, the capB assay targets the capB gene, which cannot be detected in pXO2-negative strains. 
Therefore, whilst the capB assay was negative for the bacterial species tested (data not shown), a 
limitation was there was no positive control for capB.
The PCR enriched targets were quantitated using fluorometry (Qubit® 2.0 fluorometer) and ranged 
in concentration from 2.39 – 13.6 ng/μL for the Canberra Airport samples. No product was detected 
for the NTC or TE controls.
Prior to the library preparation steps, pooled DNA quantity and quality post-purification was 
evaluated by microfluidic capillary electrophoresis on the Bioanalyzer. Electropherograms of the B. 
thuringiensis and B. anthracis Sterne strain (pXO1+ pXO2-) controls produced peaks at 184 base pairs 
(bp) and 150 bp indicating the presence of the 16S rRNA and cya (pXO1) gene targets, respectively 
(Figure 1).
Figure 1: Electropherograms of B. thuringiensis and B. anthracis controls post-target pooling
Plots display (A) B. thuringiensis subsp. Kurstaki and (B) B. anthracis Sterne strain (pXO1+ pXO2-) 
controls post-target pooling. LP = lower ladder peak; UP = upper ladder peak; 16S = peak indicating 
16S rRNA gene; pXO1 = peak indicating cya gene harboured on pXO1.
Electropherograms of the Canberra Airport samples were found to contain low DNA quantities and 
hence low fluorescent intensity (data not shown). For this reason, the electropherograms of both B. 
thuringiensis and B. anthracis Sterne strain controls were evaluated for the successful ligation of the 
60 bp adapter. Electropherograms performed post-library preparation resulted in controls with 
peaks at 245 bp and 210 bp, indicating a presence of the 16S rRNA and cya genes with the additional 
adapter, respectively (Figure 2). Furthermore, there was no dominant peak below 100 bp suggesting 
no adapter dimer. DNA concentration was measured by smear analysis from the expected range of 
100 – 300 bp and the B. anthracis and B. thuringiensis controls had concentrations of 2.50 ng/μL and 
0.44 ng/μL, respectively. The DNA concentrations of the Canberra Airport samples were all less than 
0.28 ng/μL. 
Figure 2: Electropherograms of B. thuringiensis and B. anthracis controls post-library preparation
Plots display (A) B. thuringiensis subsp. Kurstaki and (B) B. anthracis Sterne strain (pXO1+ pXO2-) 
controls post-library construction. LP = lower ladder peak; UP = upper ladder peak; 16S = peak 
indicating 16S rRNA gene; pXO1 = peak indicating cya gene harboured on pXO1. 
Chip 1 and chip 2 were loaded to 73 % and 74 % capacity, respectively. For chip 1, 912,207 library 
ISPs were enriched, of which 16.4 % (or 150,040) produced usable reads. For chip 2, a total of 
924,698 ISP loading was reported and from these 4.9 % (or 45,345) produced reads that could be 
utilised for downstream applications. The usable read percentage was calculated by the Torrent 
Suite™ after the ISPs were filtered for being of low quality (chip 1 = 20.8 %; chip 2 = 11.3 %), 
polyclonal (chip 1 = 54 %; chip 2 = 80.2 %) or exhibiting adapter dimer (chip 1 = 8.2 %; chip 2 = 1.6 
%). For both chips, read lengths ranged from 148-184 bp which was consistent with the expected 
read lengths of 184 bp (16S rRNA), 150 bp (cya) and 148 bp (capB). A large number of reads were 
below 50 bp, indicating adapter dimer.
Individual sample FASTQ files were imported into the Mac OS X Terminal and underwent quality 
control measures prior to Bowtie2 alignment. An alignment of reads from the positive controls to 
the B. anthracis Ames ancestor genome reference (NC_007530.2) resulted in a high abundance of 
16S rRNA reads for both B. thuringiensis subsp. Kurstaki and B. anthracis Sterne strain (Figure 3). The 
latter also had reads that mapped to the cya gene harboured on pXO1. Conversely, the negative 
controls (TE buffer and NTC) returned no read alignment. A total of 16 of the 20 (80 %) Canberra 
Airport samples were positive for the B. cereus group target of 16S rRNA across chip 1 (Figure 3A) 
and chip 2 (Figure 3B). These samples were collected in December 2011 and February, April and June 
2012. There was a trend towards a higher abundance of 16S rRNA reads at the Canberra Airport in 
the luggage out (LO) samples and the Australian Air Express freight departing (FO). Nine of the 20 (40 
%) Canberra Airport samples aligned to the B. anthracis Ames ancestor pXO1 reference 
(NC_007322.2) and all were collected in February 2012. Of the samples positive for cya, there was a 
higher abundance and occurrence in two different sites for people leaving (PO and POV) the airport. 
A total of 15 of the 20 (70 %) samples aligned to the B. anthracis Ames ancestor pXO2 reference 
(NC_007323.3) with two of these collected from the Australian Air Express site (freight departing 
(FO) and arriving (FI)) in August and December 2011. The sampling sites with the highest incidence of 
cya alignment across all months were people (PO and POV) and luggage (LO) departing the Canberra 
Airport. Five samples were positive for all three targets (16S rRNA, cya and capB). These were 
collected in February 2012 and comprised of two samples from luggage departing and one sample 
from each of the people departing and low traffic control (LC) sites. As a consequence of mapping a 
moderate set of reads to a small set of targets, a high proportion of the data remained unmapped, 
particularly for the controls of NTC and TE buffer (100 %) and CA9LI20.6 (99 %).
Figure 3: Relative abundance and bacterial target composition of the Canberra Airport samples 
and controls
Plots display relative abundance of sample sequence reads in chip 1 (A) and chip 2 (B) that aligned to 
specific targets as well as unaligned reads. The x-axis represents the individual samples and the y-
axis the percentage of reads reported. BA = B. anthracis Sterne strain; BT1 = B. thuringiensis subsp. 
Kurstaki; NTC = no-template control; TE = Tris-EDTA buffer solution. Colours are based on the three 
targets, navy blue = 16S rRNA gene; light blue = cya gene on pXO1; green = capB gene on pXO2; 
yellow = unaligned reads.
3.2 Ion 16S™ Metagenomics Kit (MPS 2)
For MPS 2, the Ion 520 chip was loaded to 93 % capacity with 100 % enrichment. Of the 11,603,369 
total reads 4,618,388 (40 %) were considered usable. The usable read percentage was calculated by 
the Torrent Suite™ after the ISPs were filtered for being of low quality (28.3 %), polyclonal (31.8 %) 
or exhibiting adapter dimer (0.1 %). The mean, median and mode read lengths were 241 bp, 261 bp 
and 289 bp, respectively.
For the positive (E. coli) control, a total of 91 identifications were reported (across all primer targets) 
with all being members of the Enterobacteriaceae family. For the negative control a total of 168 
sequence identifications were reported (across all primer targets) with these predominantly 
comprising of members of the Proteobacteria and Firmicutes phylum with smaller numbers of 
members of Cyanobacteria, Bacteroidetes and Actinobacteria. The top three identifications for the 
negative control at the species level, in terms of % of mapped reads, were Corynebacterium 
tuberculostearicum (27.94 %), Propionibacterium acnes (7.79 %) and Cupriavidus/Ralstonia sp. (6.76 
%). At the species level for the negative control there was only one report for Bacillus and this was 
with primer V2 for Bacillus mycoides/Bacillus weihenstephanensis at 0.25 % of mapped reads.
For the Canberra Airport samples the number of sequencing identifications ranged from 862 for 
CA7FI19.12 up to 2643 for CA9LC25.2 (Table 4). The average number of phyla identified was 15 with 
a minimum of 11 (CA0POV21.2) and a maximum of 21 (CA11LO23.4). At the genus/family level there 
was a variation in the predominant bacteria in each sample, however, across all eight samples, 
Staphylococcus, Nostocaceae and Propionibacterium were the most predominant bacteria appearing 
in the top three identifications for five, four and four of the eight Canberra Airport samples, 
respectively (Table 4).
Table 4: Summary of sequencing results for Ion 16S™ Metagenomics Kit
Sample Total number 
of ID
Number of phyla Top 3 ID (% mapped reads)
CA9LO20.2 2091 15 Nostocaceae (F, 2.55)
Staphylococcus (G, 2.08)
Propionibacterium (G, 1.41)
CA9LC25.2 2643 17 Propionibacterium (G, 3.2)
Nostocaceae (F, 2.06)
Propionibacterium (G, 1.64)
CA9POV20.2 1237 12 Methylobacterium (G, 8.84)
Methylobacterium (G, 8.84)
Methylobacterium (G, 6.75)
CA9LO25.2 1364 13 Nostocaceae (F, 3.2)
Staphylococcus (G, 2.69)
Rickettsiella (G, 2.61)
CA9POV21.2 1419 11 Staphylococcus (G, 3.41)
Acinetobacter (G, 2.44)
Nostocaceae (F, 2.06)
CA7FI19.12 862 14 Pseudomonas (G, 2.96)
Acinetobacter/Arsenophonus (G, 2.52)
Enterococcus (G, 1.56)
CA11LO23.4 2582 21 Staphylococcus (G, 3.36)
Rickettsiella (G, 1.68)
Propionibacterium (G, 1.58)
CA13LO20.6 1845 19 Staphylococcus (G, 5.13)
Propionibacterium (G, 2.76)
Corynebacterium (G, 1.35)
Results are reported across all primer targets down to the genus (G) or the family (F) where genus 
level resolution was not reported. ID = identifications.
To enable a comparison with MPS 1, the data from MPS 2 was mined for all Bacillus species. At the 
genus level Bacillus was identified in all eight Canberra Airport samples ranging from 0.73 % 
(CA9LO25.2) to 2.1 % (CA9LO20.2) of all identifications (Table 5). The B. cereus group (B. anthracis/B. 
cereus/B. mycoides/B. thuringiensis/B. weihenstephanensis) was also identified in all eight samples 
and, with the exception of CA9POV20.2 and CA9POV21.2, was within the top three Bacillus 
identifications. For all eight samples B. decisifrondis was identified in the top three Bacillus 
identifications (Table 5).
Table 5: Summary of Bacillus sequencing results for Ion 16S™ Metagenomics Kit
Sample ID to 
Bacillus 
genus
Bacillus ID 
as a 
percentage 
of all ID
Top 3 Bacillus species (% mapped reads)
CA9LO20.2 44 2.1 1. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.23)
2. B. decisifrondis (0.13)
3. B. aquimaris / B. carboniphilus / B. mojavensis / B. 
pseudalcaliphilus / Bacillus sp. DSM 8802 / B. subtilis / 
B. tequilensis (0.10)
CA9LC25.2 25 0.95 1. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.15)
2. B. aquimaris / B. carboniphilus / B. mojavensis / B. 
pseudalcaliphilus / Bacillus sp. DSM 8802 / B. subtilis / 
B. tequilensis (0.12)
3. B. decisifrondis (0.10)
CA9POV20.2 10 0.80 1. B. decisifrondis (0.17)
2. B. mojavensis / Bacillus sp. DSM 8802 (0.07)
3. B. aquimaris / B. carboniphilus / B. mojavensis / B. 
pseudalcaliphilus / Bacillus sp. DSM 8802 / B. subtilis / 
B. tequilensis (0.07)
CA9LO25.2 10 0.73 1. B. decisifrondis (0.22)
2. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.11)
3. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.04)
CA9POV21.2 13 0.92 1. B. decisifrondis (0.23)
2. B. clausii / B. rhizosphaerae (0.05)
3. B. rhizosphaerae (0.03)
CA7FI19.12 10 1.16 1. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.47)
2. B. cereus / B. thuringiensis (0.27)
3. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.22)
CA11LO23.4 30 1.16 1. B. decisifrondis (0.22)
2. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.15)
3. B. cereus / B. thuringiensis (0.06)
CA13LO20.6 20 1.08 1. B. decisifrondis (0.35)
2. B. anthracis / B. cereus / B. mycoides / B. thuringiensis 
/ B. weihenstephanensis (0.06)
3. B. flexus / B. megaterium (0.05)
ID = identifications
3.3 Comparison of sequencing and real-time PCR for identification of Bacillus species
With the exception of CA9POV20.2, which was detected by MPS 2 only, albeit not within the top 
three Bacillus identifications, both MPS approaches consistently identified the B. cereus group in the 
eight common samples (Table 6). For the chromosomal target there was 70 % (14/20 samples) and 
63 % (5/8 samples) consistency between MPS 1 and qPCR and between MPS 2 and qPCR, 
respectively. Three samples (CA9POV21.2, CA7FI19.12 and CA13LO20.6) were MPS positive (both 
approaches) and qPCR negative. Two samples (CA9LI20.6 and CA9POV22.2) were positive by qPCR 
but negative by MPS 1 and not tested using MPS 2 (Table 6).
Overall, MPS 1 was able to detect a higher incidence of plasmid markers in the Canberra Airport 
samples, compared with qPCR (Table 6). For cya, MPS 1 detected the target in an additional four 
samples, although for two samples, CA9LC24.2 and CA9LC25.2, MPS did not detect cya which 
contradicts the qPCR. For capB, MPS detected the target in an additional 12 samples compared to 
qPCR but in contrast did not detect the target in CA9POV21.1 (Table 6). It should be noted the 
additional MPS 1 plasmid detections were at low abundance, suggesting they were below qPCR 
quantifiable levels. 
Table 6: Comparison of real-time polymerase chain reaction (qPCR) and massively parallel 
sequencing (MPS) identifications
pXO1 pXO2 Chromosome
cya capB PL3 16S rRNA 
(B. cereus 
group)
16S rRNA 
(B. cereus 
group)
qPCR MPS 1 MPS 2 qPCR MPS 1 MPS 2 qPCR MPS 1 MPS 2
CA9POV20.2 + + nt - + nt + - +
CA9LC20.2 + + nt - + nt + + nt
CA9PO21.2 + + nt - + nt + + nt
CA9LO21.2 + + nt - + nt + + nt
CA11LO23.4 - - nt - - nt + + +
CA11PO29.4 - - nt - + nt + + nt
CA11LI29.4 - - nt - + nt + + nt
CA9LO20.2 - - nt - + nt + + +
CA9LC24.2 + - nt - + nt + + nt
CA9LC25.2 + - nt - - nt + + +
CA9POV21.2 + + nt + - nt - + +
CA13LO21.6 - + nt - + nt + + nt
CA7FI19.12 - - nt + + nt - + +
CA13LO20.6 - - nt + + nt - + +
CA9LI20.6 - - nt - - nt + - nt
CA9POV22.2 - + nt - + nt + - nt
CA9LO24.2 - + nt - + nt + + nt
CA9LO25.2 - + nt - - nt + + +
CA11POV29.4 - - nt - + nt + + nt
S56FO20.8 - - nt + + nt - - nt
qPCR = target detected through qPCR as reported by Gahan et al. (2015); MPS 1 = in-house assay; 
MPS 2 = Ion 16S™ Metagenomics Kit; nt = not tested; - = not detected; + = detected.
4.0 Discussion 
The continuous threat to national and international security from a biological agent release, or a 
hoax attack, is a very real concern. Sensitive, robust and rapid methods to identify a broad range of 
biological agents, including B. anthracis, and distinguish pathogenic from non-pathogenic species, is 
an essential cornerstone to national security. B. anthracis occurs naturally in soil. In Australia 
although infections primarily occur within anthrax belt, cases of natural outbreaks have been 
reported outside of this region, possibly due to populace, freight and vehicle travel. As such, it is of 
high importance to determine the background frequency of B. anthracis at transport locations, 
including airports. Furthermore, with a range of detection assays available, it is important to assess 
the applicability of each and determine the most appropriate for the situation. We have previously 
reported background levels of B. anthracis at the Canberra Airport over the period August 2011 – 
July 2012 using single-plex qPCR with a B. anthracis genomic (PL3 gene) and two plasmid (cya and 
capB genes) targets (Gahan et al., 2015). The aim of this study was to use two MPS approaches, on a 
sub-set of the Canberra Airport samples, and compare findings to the previous qPCR results. 
The qPCR results showed a peak of positive B. anthracis markers in February 2012, with secondary 
peaks in April and June 2012. Eleven of the 20 samples selected for the in-house assay were from 
February 2012, four were from April and three were from June 2012. The majority were from the 
luggage departing sampling area. The five samples identified by Gahan et al. (2015) as B. anthracis 
positive for the genomic marker PL3 and cya gene on pXO1 were included in this study. Two 
virulence plasmids (cya and capB genes) and a conserved B. cereus group (16S rRNA gene) marker 
were targeted with the in-house assay which allowed for the presumptive identification of 
pathogenic and non-pathogenic B. anthracis, however, it must be noted that, in contrast to the qPCR 
chromosomal target (PL3), the 16S rRNA target was not specific for B. anthracis and can only resolve 
identification to the B. cereus group. This allowed us to survey a broader spectrum of bacteria. Eight 
of these 20 samples were also sequenced using the commercial Ion 16S™ Metagenomics Kit which 
targeted multiple hypervariable regions of the bacterial 16S region, and, like the in-house assay, 
could only resolve identification to the B. cereus group.
For MPS 1, chips were loaded to 73 % (chip 1) and 74 % (chip 2) capacity with 16.4 % (chip 1) and 4.9 
% (chip 2) reported as usable. The greatest loss of potential reads was due to polyclonality (54 % 
chip 1 and 80.2 % chip 2) implying that more than one unique amplicon attached to each ISP. For 
MPS 2 there was a higher percentage (40 %) of useable reads but there was still a high polyclonal 
percentage (31 %). High polyclonality is generally caused by overloading the ISPs and may have been 
the result of inaccurate (underestimated) library quantitation before pooling.
Both MPS 1 negative controls (NTC and TE) received significant coverage (352 and 626 mapped 
reads, respectively) and bacterial DNA was also detected in the negative control for MPS 2. The top 
three identifications for the MPS 2 negative control at the species level were C. tuberculostearicum, 
P. acnes and Cupriavidus/Ralstonia sp. which are all skin contaminants and not surprising given the 
high number of skin cells shed by individuals. While none of the reads in negative controls mapped 
to the B. anthracis targets, the presence of bacterial amplicons demonstrates the difficulty in 
removing all bacterial DNA from water and buffers and hence the importance of including negative 
controls in MPS assays using broad 16S rRNA targets.
With the exception of CA9POV20.2, which was detected by MPS 2 only, both MPS approaches 
consistently identified the B. cereus group in the eight common samples (Table 6). Although it could 
be hypothesized that this difference is due to the different sequencers used (Ion PGM for MPS 1 and 
Ion S5 for MPS 2) a more likely explanation is the increased number of primer targets for MPS 2. In 
contrast to MPS 1 which targeted only a single chromosomal target, MPS 2 has six chromosomal 
targets which is likely to increase the sensitivity and broad range of the assay to detect bacteria. 
Whilst for both assays the chromosomal target(s) could only resolve identification to the B. cereus 
group, a further limitation of MPS 2 is that, in contrast to MPS 1, it does not contain targets for the 
B. anthracis virulence plasmids so cannot provide any information on pathogenicity.
For the chromosomal target there was 70 % (14/20 samples) and 63 % (5/8 samples) consistency 
between MPS 1 and qPCR and between MPS 2 and qPCR, respectively. Samples which were positive 
by both MPS and qPCR can be reported as positive for B. anthracis however, based on the 
chromosomal target alone, it is unknown whether this is pathogenic or non-pathogenic. Three 
samples (CA9POV21.2, CA7FI19.12 and CA13LO20.6) were MPS positive (both approaches) and qPCR 
negative suggesting these samples contain a member of the B. cereus group other than B. anthracis. 
Overall MPS 1 was able to detect a higher incidence of B. anthracis plasmid markers in Canberra 
Airport samples, particularly capB, compared with qPCR, and has detected both plasmid markers in 
five samples (Table 6), along with a 16S rRNA B. cereus target. This is likely due to the sensitivity of 
MPS which can theoretically identify a single DNA molecule in a noisy background. Whilst this could 
suggest pathogenic B. anthracis may be present, without culture there is no way to confirm that all 
three targets came from the same live cell and in fact that this is pathogenic B. anthracis as there 
have also been reported cases of pXO-like plasmids in other Bacillus species (Luna et al. 2006; 
Pannucci et al. 2002; Wright et al. 2011).
There were cases where samples previously reported as positive by qPCR were found to be negative 
by MPS 1. These were CA9LI20.6 and CA9POV22.2 for the chromosomal target, CA9LC24.2 and 
CA9LC25.2 for cya and CA9POV21.2 for capB. The DNA used for MPS was stored since 2012 and 
during the optimisation of MPS target enrichment and subsequent library preparation, underwent 
multiple freeze-thaw cycles. As a result, there may have been a loss in concentration and as such the 
targets may have degraded. These samples were not tested with MPS 2.
The MPS 1 and MPS 2 assays target broad 16S rRNA target(s) instead of the PL3 B. anthracis genomic 
target used in the qPCR. Whilst this means the MPS is not specifically targeted to the detection of B. 
anthracis it does provide for a broader range screening approach. This could be seen with the MPS 2 
results (Table 4) in which the top three identifications were commonly Staphylococcus, Nostocaceae 
and Propionibacterium species but also included other species such as Pseudomonas and 
Rickettsiella. These findings are not surprising, given many of these are members of the normal flora 
commonly found in the environment, and a broad range target allows for greater information to be 
obtained from samples and a metagenomic fingerprint to be created. Although the MPS 1 data was 
only mined for Bacillus there was a high number of unmapped reads (i.e. not specific to Bacillus) so 
further work is recommended to focus on this data and compare the metagenomic fingerprint of 
both sequencing approaches. This will further contribute to an understanding of the overall bacterial 
composition of the Canberra Airport and enable additional conclusions to be drawn regarding the 
sensitivity and detection ability of both MPS assays. 
Monthly samples collected by Gahan et al. (2015) at several locations from porous and non-porous 
surfaces at the Canberra Airport and Australian Air Express freight between August 2011 - July 2012, 
allowed for a detailed analysis of seasonal and locational variation. The key finding was a higher 
incidence of positive B. anthracis targets in February, April and June 2012. This finding was 
supported by MPS. Of the 15 samples positive for the B. cereus group by MPS 1, two samples were 
also pXO1-positive in February 2012 and seven were also pXO2-positive (December 2011 and June 
2012). A total of five samples aligned to all three markers, of which four were collected in February 
2012. As discussed in Gahan et al. (2015), Queensland and NSW experienced flooding during 
December 2011 – January 2012, which may have caused a peak in B. anthracis. Environmental and 
climatic factors have a great influence on the ecology of B. anthracis, especially rainfall and 
temperature (Blackburn et al., 2007). Daytime temperatures in February 2012 at the Canberra 
Airport were above the average at 30 – 31 °C with moderate winds (2 – 24 km/h) and relatively high 
humidity (approximately 74 %) (Time and Date, 2012). Another likely scenario may be increased 
bacterial prevalence due to heightened foot traffic in February associated with returning passengers 
from Christmas and school holidays or passengers celebrating the Lunar New Year period from late 
January to early February (Freed, 20 March 2015). 
Due to the low number of samples sequenced no conclusions can be drawn from MPS regarding 
whether the positive samples were associated with the movement of luggage, people and/or freight 
in and/or out of the airport. Interestingly, one of the low traffic control samples which is situated 
under an escalator, and so away from foot traffic and less likely to be cleaned regularly, was positive 
for all three markers by MPS. This suggests that once bacteria enter the airport they disperse, 
possibly due to the use of the heating–ventilation–air-conditioning (HVAC) units in operation 
throughout the building interior. There have been a number of studies which have demonstrated the 
dispersal and migration of microorganisms by people, air movement, HVAC and electrostatic forces 
in the indoor urban environment (Li et al., 2007; Prussin et al., 2015; Tringe et al., 2008). Sextro et al. 
(2002) in particular, employed predictive modelling to examine the dispersion of B. anthracis spores 
in a building from a single point of origin, while Van Cuyk et al. (2012) used an aerosolised simulant 
(B. thuringiensis) to model the movement from an outdoor release into a building. These dispersal 
studies highlight that in future work sampling of the air duct surfaces, in conjunction with air 
sampling, is recommended. 
Like any method for bacterial species identification, there are drawbacks associated with MPS. 
Limiting factors include the cost, time and current restriction of analyses in a laboratory 
environment. Having said this, sequencing costs are falling and third generation sequencing, such as 
single-molecule real-time sequencing (SMRT), eliminates the time-consuming steps in template 
amplification and provides for a field-portable system that can plug into a standard universal serial 
bus (USB 3.0) port on a computer (for a review see Schadt et al., 2010). SMRT platforms have been 
integrated into systems developed by Oxford Nanopore Technologies (MinION™, SmidgION™ and 
PromethION™; for a review see Lu et al., 2016) and Pacific Biosciences (Sequel system and PacBio RS 
II; for a review see Rhoads et al., 2015). SMRT platforms have already demonstrated their diagnostic 
capabilities for rapid outbreak management in the field during the Ebola epidemic in Guinea, West 
Africa (Quick et al., 2016).
5.0 Conclusions 
Overall, the sensitivity of MPS technology allowed for greater detection of Bacillus species at the 
Canberra Airport compared to qPCR. Whilst the broad-range 16S genomic target(s) used in both MPS 
approaches was able to generate a metagenomic fingerprint of the bacterial community at the 
Canberra Airport, unlike the PL3 target used in the qPCR, it could not resolve Bacillus species beyond 
the level of the B. cereus group. The inclusion of B. anthracis virulence plasmid targets in MPS 1 did 
allow for presumptive identification of pathogenic species. These targets were not present in MPS 2. 
The choice of target(s) is therefore key in MPS assay development and should be carefully 
considered to ensure the assay is fit for purpose, whether as an initial screening (presumptive) or a 
more specific test. Identification approaches may also benefit from a combination of MPS and qPCR. 
A limitation of molecular techniques, including qPCR and MPS, is that they are unable to provide a 
true confirmation because even if all three B. anthracis targets (chromosomal, pXO1 and pXO2) are 
identified in the one sample, it does not necessarily mean that a live pathogenic strain is present, 
rather, just the DNA sequences are present. The source may not be cellular in origin and could be 
dead cells or spores or there may be multiple bacteria present each with a different target. 
Nevertheless, the presence of all three would provide justification to send the sample for “gold 
standard” identification by culturing which is time-consuming and requires a high-level containment 
laboratory.
There is room for further work on the full collection of the 2011 – 2012 Canberra Airport samples. 
Sequencing of additional samples, and detailed analysis of the full sequencing data generated, would 
provide a greater understanding of the bacterial community at the Canberra Airport and enhance 
our understanding of the relationship of bacterial occurrence with: (1) fluctuations in flight volume 
and foot traffic during the holiday seasons and (2) the effects of the summer climate which draw 
heightened conditioned air from the HVAC system. Studies could be extended to other 
transportation hubs, including those within the anthrax belt, to provide a large-scale database of 
background levels of microorganisms.
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